SCHEMBL2017397

SCHEMBL2017397

CN(C(=O)c1cn2ccsc2n1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.57
HCRTR2 O43614 2/20 0.57
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
TSHR P16473 2/20 0.40
HPGD P15428 3/20 0.39
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HTT P42858 1/20 0.38
PADI4 Q9UM07 3/20 0.36
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
OPRM1 P35372 1/20 0.35
NLRP3 Q96P20 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014229 0.86 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9AHPGD
SCHEMBL2014309 0.85 HCRTR1 (0.57) HCRTR1HCRTR2NPC1RAB9ATSHR
SCHEMBL2012177 0.84 HCRTR1 (0.58) HCRTR1HCRTR2NPC1RAB9AHPGD
SCHEMBL2018124 0.84 HCRTR1 (0.55) HCRTR1HCRTR2NPC1RAB9AHPGD
SCHEMBL2014316 0.84 HCRTR1 (0.55) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2015686 0.84 HCRTR1 (0.55) HCRTR1HCRTR2NPC1RAB9AHPGD
SCHEMBL2014646 0.83 HCRTR1 (0.56) HCRTR1HCRTR2NPC1RAB9APOLB
SCHEMBL6918074 0.82 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9ATSHR
SCHEMBL2014627 0.82 HCRTR1 (0.59) HCRTR1HCRTR2NPC1RAB9ATSHR
SCHEMBL2013183 0.82 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed